Trump then: Won't hesitate in banning lobbyists. Trump now: You're hired

Donald Trump suggested during the campaign that he would ban lobbyists from his administration

Donald Trump, Shinzo Abe
Justin Elliott | ProPublica
Last Updated : Feb 15 2017 | 8:27 AM IST

During his campaign, Donald Trump repeatedly welcomed the idea of banning lobbyists from his administration.

Fast forward eight months, and now-President Trump is welcoming them in.

Last June on CBS's "Face the Nation," host John Dickerson asked Donald Trump: Given the candidate's drumbeat of criticism of the Washington lobbyist class, "Will you say 2018No lobbyists will work for me and no big donors?'"

"I would have no problem with it, honestly," Trump responded.

After the exchange, a "Face the Nation" producer followed up with campaign spokeswoman Hope Hicks, who confirmed that, yes, Trump was referring to banning lobbyists from his administration.

The sentiment is in line with what Trump told NBC's "Meet the Press" in another interview a year earlier, when he called banning lobbyists from working in his administration "a pretty good idea."

As ProPublica detailed last week, a longtime construction industry lobbyist who previously worked against wage and workplace safety regulations is now in a key position at the Department of Labor. The lobbyist, Geoff Burr, is reportedly in line to be chief of staff if Andrew Puzder is confirmed as Labor secretary.

At the Food and Drug Administration, longtime pharmaceutical lobbyist Jack Kalavritinos has a senior role in the agency's early Trump team, according to Stat News.

Kalavritinos spent more than seven years as the chief lobbyist of the medical device and pharmaceutical firm Covidien. (Covidien was subsequently acquired by Medtronic.) In that role, Kalavritinos lobbied the FDA and Congress on a host of issues related to medical device regulation, disclosure records show. Among the legislation he lobbied on was the Novel Device Regulatory Relief Act and the Food and Drug Administration Mission Reform Act.

Trump himself recently criticized the extensive influence of the pharmaceutical lobby. "Pharma has a lot of lobbies and a lot of lobbyists and a lot of power and there's very little bidding on drugs," he said at a press conference last month.

K Street was a frequent punching bag for Trump on the campaign trail. He once tweeted:

It's difficult to know how many former lobbyists are now working in the Trump administration. Both Burr and Kalavritinos are members of Trump's so-called "beachhead teams," which are made up of officials installed at federal agencies to lay the groundwork while the president's nominees make their way through the Senate confirmation process. The administration has said there are around 500 such staffers, but has not released a list of names.

Trump last month issued an executive order on ethics for appointees that weakened elements of the Obama-era policy on former lobbyists joining government.

Trump also hired a range of lobbyists into influential positions during the transition period, between Election Day and the inauguration on Jan. 20. As The New York Times noted in November, telecom, energy, and agriculture industry consultants and lobbyists were all named to influential roles.

The White House did not respond to a request for comment.

ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for their newsletter.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story